Products intended or expected to be sterile were prepared, packed, or held under unsanitary conditions.Essential Extras: Tailstorm initiated a voluntary recall of the drug bevacizumab in November 2024 due to concerns over sterility.Types of Products Made: Pre-filled sterile injectable products and repackaged products, including single-dose liquid injectable vialsLink: FDA Warning LetterRead the warning letter for a complete description of violations
There are a few considerations
Huang, S., Lan, Y., Zhang, C., Zhang, J
We want our patients to note that these injections should only be used under the supervision of a skilled professional at our practice and in conjunction with a healthier diet and sustainable exercise plan
Methods This real-world, retrospective, observational cohort study included adults with obesity or overweight with 1 obesity-related complication treated with semaglutide 2.4 mg identified in a large US claims and medical record database (December 15, 2020, through May 30, 2024)